Hypotension

Sudoscan and Cardiovascular outcomes in Hemodialysis

Cardiac neuropathy, Scientific publications / By Impeto Medical

Association of Electrochemical Skin Conductance by Sudoscan and Cardiovascular Outcomes in Hemodialysis Patients M Touzot et al. Kidney Int Rep (2022) 7, 2734–2736 Article reference: https://www.kireports.org/article/S2468-0249(22)01774-0/fulltext We recently reported for the first time, the clinical pertinence of the Sudoscan to assess dysautonomia to predict intradialytic hypotension. In a 24-month follow-up of the original cohort, we …

Sudoscan and Cardiovascular outcomes in Hemodialysis Read More »

SUDOSCAN in Intradialytic hypotension

Nephrology, Scientific publications / By Impeto Medical

SUDOSCAN in Intradialytic hypotension Electrochemical skin conductance by SUDOSCAN: a new tool to predict intradialytic hypotension Pauline Reach, Maxime Touzot, Yannis Lombardi, Catherine Maheas, Emmanuelle Sacco, Audrey Fels, Hélène Beaussier, Pablo Ureña-Torres, Gilles Chatellier, Christophe Ridel, Mathieu Zuber.Article title: Electrochemical skin conductance by Sudoscan®: a new tool to predict intradialytic hypotension.Nephrology Dialysis Transplantation, gfab183. P. Reach …

SUDOSCAN in Intradialytic hypotension Read More »

Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12